IntroductionThe Lennox-Gastaut Syndrome (LGS) Market is an important part of the global rare neurological disorder therapeutics landscape. Lennox-Gastaut Syndrome is a severe form of epilepsy that typically begins in early childhood, characterized by multiple types of seizures, cognitive impairment, and resistance to standard antiepileptic treatments. The market is driven by increasing awareness of rare neurological […]